Try our mobile app

Published: 2021-02-09 07:41:06 ET
<<<  go to CTS company page
EX-99.1 2 cts-ex991_6.htm EX-99.1 cts-ex991_6.htm

 

 

Press Release

 

 

 

February 9, 2021

 

FOR IMMEDIATE RELEASE

 

 

 

CTS Announces Fourth Quarter and Full Year 2020 Results

 

Continued market recovery, solid operational performance

Lisle, Ill. - CTS Corporation (NYSE: CTS) today announced fourth quarter and full year 2020 results.

Fourth Quarter 2020 Results

Sales were $123 million, up 7% year-over-year. Sales to transportation customers increased 12%, and sales to other end markets were essentially flat.

Net earnings were $14.9 million or $0.46 per diluted share versus $10.1 million or $0.31 last year.

Adjusted diluted EPS was $0.43, up 16% from $0.37 in the fourth quarter of 2019.

Free cash flow was $22.0 million, up 28% from $17.2 million in 2019.

New business wins were $104 million.

Full Year 2020 Results

Sales were $424 million, down 10% compared to 2019. Sales to transportation customers declined 19%, and sales to other end markets increased 7%.

Net earnings were $34.7 million or $1.06 per diluted share versus $36.1 million or $1.09 last year.

Adjusted diluted EPS was $1.12 compared to $1.45 in 2019.

Free cash flow was $61.9 million, up 45% from $42.7 million last year.

New business wins were $442 million.

“We saw strength in most end markets and executed well to deliver solid financial results in the fourth quarter,” said Kieran O’Sullivan, CEO of CTS Corporation. “We are making progress on our Focus 2025 strategic initiative, including a target of 10% annualized revenue growth. The recent SSI acquisition strengthens our position with medical customers and advances our end market diversification.”

2021 Guidance

Management remains mindful of market and supply chain uncertainties in this pandemic environment. Full year 2021 sales are expected to be in the range of $430 to $490 million. Adjusted earnings per diluted share for 2021 are expected to be in the range of $1.20 to $1.60. Management aims to narrow the guidance range as the year progresses.

 


Conference Call

As previously announced, the Company has scheduled a conference call at 10:00 a.m. (EST) today to discuss the fourth quarter and full year financial results. The dial-in number is 800-309-1256 (720-543-0314, if calling from outside the U.S.).  The passcode is 886676. There will be a replay of the conference call from 1:00 p.m. (EST) today through 1:00 p.m. (EST) on Tuesday, February 23, 2021.  The telephone number for the replay is 888-203-1112 (719-457-0820, if calling from outside the U.S.).  The replay passcode is 8354721. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at www.ctscorp.com.

About CTS

CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move.  The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, telecommunications/IT, and transportation markets.

For more information, visit www.ctscorp.com.

Safe Harbor

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management's expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Many of these, and other, risks and uncertainties are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K. We undertake no obligation to publicly update our forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

Contact

 

Ashish Agrawal

Vice President and Chief Financial Officer

 

CTS Corporation

4925 Indiana Avenue

Lisle, IL 60532

USA

 

Telephone: +1 (630) 577-8800

E-mail: ashish.agrawal@ctscorp.com

 


CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - UNAUDITED

(In thousands of dollars, except per share amounts)

 

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

December 31,

2020

 

 

December 31,

2019

 

 

December 31,

2020

 

 

December 31,

2019

 

Net sales

 

$

123,018

 

 

$

115,040

 

 

$

424,066

 

 

$

468,999

 

Cost of goods sold

 

 

80,327

 

 

 

76,340

 

 

 

285,003

 

 

 

311,424

 

Gross margin

 

 

42,691

 

 

 

38,700

 

 

 

139,063

 

 

 

157,575

 

Selling, general and administrative expenses

 

 

19,476

 

 

 

18,037

 

 

 

67,787

 

 

 

70,408

 

Research and development expenses

 

 

5,664

 

 

 

6,113

 

 

 

24,317

 

 

 

25,967

 

Restructuring charges

 

 

414

 

 

 

2,111

 

 

 

1,830

 

 

 

7,448

 

Loss (gain) on sale of assets

 

 

 

 

 

48

 

 

 

 

 

 

(63

)

Operating earnings

 

 

17,137

 

 

 

12,391

 

 

 

45,129

 

 

 

53,815

 

Other (expense) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(655

)

 

 

(903

)

 

 

(3,272

)

 

 

(2,648

)

Interest income

 

 

195

 

 

 

341

 

 

 

1,047

 

 

 

1,737

 

Other income (expense), net

 

 

2,682

 

 

 

1,008

 

 

 

2,575

 

 

 

(2,638

)

Total other income (expense), net

 

 

2,222

 

 

 

446

 

 

 

350

 

 

 

(3,549

)

Earnings before income taxes

 

 

19,359

 

 

 

12,837

 

 

 

45,479

 

 

 

50,266

 

Income tax expense

 

 

4,412

 

 

 

2,775

 

 

 

10,793

 

 

 

14,120

 

Net earnings

 

$

14,947

 

 

$

10,062

 

 

$

34,686

 

 

$

36,146

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.46

 

 

$

0.31

 

 

$

1.07

 

 

$

1.11

 

Diluted

 

$

0.46

 

 

$

0.31

 

 

$

1.06

 

 

$

1.09

 

Basic weighted – average common shares outstanding:

 

 

32,273

 

 

 

32,554

 

 

 

32,317

 

 

 

32,700

 

Effect of dilutive securities

 

 

289

 

 

 

416

 

 

 

267

 

 

 

405

 

Diluted weighted – average common shares outstanding:

 

 

32,562

 

 

 

32,970

 

 

 

32,584

 

 

 

33,105

 

Cash dividends declared per share

 

$

0.04

 

 

$

0.04

 

 

$

0.16

 

 

$

0.16

 

 


CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of dollars)

 

 

 

(Unaudited)

 

 

 

 

 

 

 

December 31, 2020

 

 

December 31, 2019

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

91,773

 

 

$

100,241

 

Accounts receivable, net

 

 

80,981

 

 

 

78,008

 

Inventories, net

 

 

45,870

 

 

 

42,237

 

Other current assets

 

 

14,607

 

 

 

16,992

 

Total current assets

 

 

233,231

 

 

 

237,478

 

Property, plant and equipment, net

 

 

97,437

 

 

 

105,038

 

Operating lease assets, net

 

 

23,281

 

 

 

24,644

 

Other Assets

 

 

 

 

 

 

 

 

Prepaid pension asset

 

 

56,642

 

 

 

62,082

 

Goodwill

 

 

109,497

 

 

 

106,056

 

Other intangible assets, net

 

 

79,121

 

 

 

85,215

 

Deferred income taxes

 

 

24,250

 

 

 

19,795

 

Other

 

 

2,590

 

 

 

3,046

 

Total other assets

 

 

272,100

 

 

 

276,194

 

Total Assets

 

$

626,049

 

 

$

643,354

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

50,489

 

 

$

48,219

 

Operating lease obligations

 

 

3,294

 

 

 

2,787

 

Accrued payroll and benefits

 

 

12,978

 

 

 

9,564

 

Accrued expenses and other liabilities

 

 

38,171

 

 

 

36,378

 

Total current liabilities

 

 

104,932

 

 

 

96,948

 

Long-term debt

 

 

54,600

 

 

 

99,700

 

Long-term operating lease obligations

 

 

23,163

 

 

 

24,926

 

Long-term pension obligations

 

 

7,466

 

 

 

6,632

 

Deferred income taxes

 

 

7,010

 

 

 

5,637

 

Other long-term obligations

 

 

5,196

 

 

 

4,292

 

Total Liabilities

 

 

202,367

 

 

 

238,135

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

 

 

 

Common stock

 

 

311,190

 

 

 

307,932

 

Additional contributed capital

 

 

41,654

 

 

 

43,689

 

Retained earnings

 

 

539,281

 

 

 

509,766

 

Accumulated other comprehensive loss

 

 

(95,921

)

 

 

(91,726

)

Total shareholders’ equity before treasury stock

 

 

796,204

 

 

 

769,661

 

Treasury stock

 

 

(372,522

)

 

 

(364,442

)

Total shareholders’ equity

 

 

423,682

 

 

 

405,219

 

Total Liabilities and Shareholders’ Equity

 

$

626,049

 

 

$

643,354

 

 


CTS CORPORATION AND SUBSIDIARIES

OTHER SUPPLEMENTAL INFORMATION - UNAUDITED

 

Earnings Per Share

The following table reconciles GAAP diluted earnings per share to adjusted diluted earnings per share for the Company:

 

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

December 31,

2020

 

 

December 31,

2019

 

 

December 31,

2020

 

 

December 31,

2019

 

GAAP diluted earnings per share

 

$

0.46

 

 

$

0.31

 

 

$

1.06

 

 

$

1.09

 

Tax affected charges to reported diluted earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

0.01

 

 

 

0.05

 

 

 

0.04

 

 

 

0.18

 

Foreign currency (gain) loss

 

 

(0.10

)

 

 

(0.03

)

 

 

(0.16

)

 

 

0.05

 

Non-cash pension expense

 

 

0.01

 

 

 

0.01

 

 

 

0.06

 

 

 

0.02

 

Environmental charges

 

 

0.03

 

 

 

0.05

 

 

 

0.07

 

 

 

0.05

 

Legal settlement

 

 

 

 

 

(0.01

)

 

 

 

 

 

(0.01

)

Transaction costs

 

 

0.01

 

 

 

 

 

 

0.01

 

 

 

0.02

 

Discrete tax items

 

 

0.01

 

 

 

(0.01

)

 

 

0.04

 

 

 

0.05

 

Adjusted diluted earnings per share

 

$

0.43

 

 

$

0.37

 

 

$

1.12

 

 

$

1.45

 

 

Free Cash Flow

The following table reconciles GAAP operating cash flow to free cash flow for the Company:

 

 

 

Three Months Ended

 

 

Twelve Months Ended

 

(in thousands)

 

December 31,

2020

 

 

December 31,

2019

 

 

December 31,

2020

 

 

December 31,

2019

 

Net cash provided by operating activities

 

$

26,429

 

 

$

23,670

 

 

$

76,783

 

 

$

64,405

 

Capital expenditures

 

 

(4,417

)

 

 

(6,434

)

 

 

(14,858

)

 

 

(21,733

)

Free cash flow

 

$

22,012

 

 

$

17,236

 

 

$

61,925

 

 

$

42,672

 

 

Additional Information

The following table includes other financial information not presented in the preceding financial statements.

 

 

 

Three Months Ended

 

 

Twelve Months Ended

 

(in thousands)

 

December 31,

2020

 

 

December 31,

2019

 

 

December 31,

2020

 

 

December 31,

2019

 

Depreciation and amortization expense

 

$

6,851

 

 

$

6,581

 

 

$

26,670

 

 

$

24,619

 

Stock-based compensation expense

 

$

1,253

 

 

$

1,065

 

 

$

3,417

 

 

$

5,015

 

 

Non-GAAP Financial Measures

Adjusted earnings per share is a non-GAAP financial measure. The most directly comparable GAAP financial measure is diluted earnings per share.

CTS adjusts for these items because they are discrete events, which have a significant impact on comparable GAAP financial measures and could distort an evaluation of our normal operating performance.

CTS uses an adjusted earnings per share measure to evaluate overall performance, establish plans and perform strategic analysis. Using this measure avoids distortion in the evaluation of operating results by eliminating the impact of events which are not related to normal operating performance. Because this measure is based on the exclusion or inclusion of specific items, they may not be comparable to measures used by other companies which have similar titles. CTS' management compensates for


this limitation when performing peer comparisons by evaluating both GAAP and non-GAAP financial measures reported by peer companies. CTS believes that this measure is useful to its management, investors and stakeholders in that it:

 

provides a meaningful measure of CTS' operating performance,

 

reflects the results used by management in making decisions about the business, and

 

helps review and project CTS' performance over time.

Free cash flow is a non-GAAP financial measure. The most directly comparable GAAP financial measure is net cash provided by operating activities. CTS believes free cash flow is a useful measure of its ability to generate cash.

We recommend that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies.